Abstract Recently, Plasmodium knowlesi has been recognised as the fifth Plasmodium species causing malaria in humans. Hundreds of human cases infected with this originally simian Plasmodium species have been described in Asian countries and increasing numbers are reported in Europe from travellers. The growing impact of tourism and economic development in South and Southeast Asia are expected to subsequently lead to a further increase in cases both among locals and among travellers. P. knowlesi is easily misidentified in microscopy as P. malariae or P. falciparum. We developed new primers for the rapid and specific detection of this species by low-cost real-time polymerase chain reaction (PCR) and added this method to an already existing panel of primers used for the molecular identification of the other four species in one reaction. Reference laboratories should now be able to identify undisputably and rapidly P. knowlesi, as it is a potentially fatal pathogen.
Introduction
Until recently, human malaria was known to be caused only by the four species Plasmodium falciparum, P. vivax, P. ovale and P. malariae. New retrospective studies with molecular tools have also shown hundreds of human cases infected with a simian Plasmodium species, P. knowlesi, in numerous Southeast Asian countries, most in Sarawak and Sabah, Malaysian Borneo [1, 2] , others in other parts of Borneo [3] , in Peninsular Malaysia [4] , Thailand [5] , Myanmar [6] , the Philippines [7] , Singapore [8] and Vietnam [9, 10] . Concomitantly, increasing numbers have been described in travellers returning from these areas [11] [12] [13] [14] [15] [16] [17] . This parasite has been recognised in 2008 by the World Health Organization (WHO) as the fifth human Plasmodium species potentially leading to fatal outcome [18] [19] [20] . The growing impact of tourism and economic development in South and Southeast Asia are expected to subsequently lead to a further increase in cases both among locals and among travellers. Therefore, an early and accurate identification of suspected cases is warranted both in order to be able to start immediately the appropriate treatment and to improve the follow-up. analyses of asexual stages of Plasmodium on thick and thin blood films are unable to distinguish early trophozoites of P. knowlesi from P. falciparum and later erythrocytic stages from those of P. malariae [21, 22] . Molecular methods have, therefore, been described to help in the detection of this life-threatening species. Babady et al. used a first set of FRET probes in real-time polymerase chain reaction (PCR) to differentiate the four species P. falciparum, P. vivax, P. ovale and P. malariae according to different melting temperatures [23] . Based on this analysis, P. knowlesi was indistinguishable from P. vivax. Therefore, the authors have designed a second specific set of FRET probes for P. knowlesi. This assay allows the detection of the five Plasmodium species in a same run but the two sets of probes increases the cost of the reaction.
We have previously adapted with slight modifications the SYBR Green real-time PCR from de Monbrison et al. in order to identify and differentiate the four Plasmodium species, P. falciparum, P. vivax, P. ovale and P. malariae [24] . In the present study, we have expanded the method to the detection of the fifth human Plasmodium species, P. knowlesi.
Materials and methods

Bioinformatic study
In order to add the detection of P. knowlesi to the already used assay, a specific primer set was designed. A set of 87 small sub-unit gene sequences corresponding to the five Plasmodium species was recovered from two databases, GenBank (NCBI; http://www.ncbi.nlm.nih.gov/genbank/) and PlasmoDB (Malaria Parasite Genome Project; http:// plasmodb.org/). Among them, 50 correspond to P. knowlesi, with 37 sequences of A-type and 13 sequences of S-type. Ten sequences correspond to P. falciparum (five A-type and five S-type), 14 to P. vivax (11 A-type and three S-type), eight to P. ovale (seven A-type and one unidentified) and five to P. malariae (one A-type and four unidentified).
The selected sequences were aligned using the BioEdit Sequence Alignment Editor® (version 7.0.5.3). Regions of conserved alignment for P. knowlesi but with enough polymorphisms with the other four Plasmodium species were then searched for in order to design specific P. knowlesi primers.
DNA extraction and controls
Nucleic acids of blood samples were extracted by using the MagNA Pure LC automated system with the MagNA Pure LC Microbiology Kit M Grade according to the manufacturer's instructions (Roche Diagnostics, France). Samples were kept at −80°C until they were used. Two P. knowlesi samples taken from European tourists were used to control the specificity of the primers [11, 15] .
A positive control plasmid of P. knowlesi was constructed to evaluate the sensitivity of the method. DNA was amplified with the primers PkF1140 5′-GATTCATCTAT TAAGAATTTGCTTC-3′ [25] and PKg'R 5′-CAAATCC ACTATATTCAATTCTACA-3′, framing the specific region PKe'F-PKg'R and the PCR product was cloned into a plasmid (PCR Cloning kit®, Qiagen). Recombinant clones were selected and plasmid DNA was extracted, purified and quantified spectrophotometrically. Ten-fold serial dilutions in sterile water were prepared in order to obtain concentrations from 10 10 plasmid copies/μl to 10 copies/μl.
Real-time PCR
The already used analysis targets the A-type 18 S ribosomal subunit gene of Plasmodium spp. and is based on the fluorescent SYBR Green I dye used on a LightCycler (Roche Diagnostic, France). In this assay, the primers PSP1AS (5′-CTACTCCTATTAATCGTAACT-3′), PFS1 (5′-CATTTAAACTGGTTTGGGAAAAC-3′) or POS1 (5′-GCATTCCTTATCCAAAATGTG-3′) are used in order to detect P. falciparum and P. ovale, respectively, and the primers PM1 (5′-ATAACATAGTTGTACGTTAAGAATAA CCGC-3′), PM2 (5′-AAAATTCCCATGCATAAAAAAT TATACAAA-3′), PV1 (5′-CGCTTCTAGCTTAATCCA CATAACTGATAC-3′) and PV2 (5′-CTTCCAAGCC GAAGCAAAGAAAGTCCTTA-3′) are used to detect P. malariae and P. vivax [24] . The reaction is performed in a final volume of 20 μl, containing 5 μl of DNA extracted from blood samples, 5 μl of LightCycler FastStart DNA Master SYBR Green I Buffer (Roche Diagnostics, France), 2.4 μl of MgCl 2 (4 mM) and 0.6 μl of each primer (initial concentration 10 μM, final concentration 0.3 μM).
The PCR programme is similar for the five Plasmodium species: after an initial denaturation step of 8 min at 95°C, 40 cycles of denaturation at 95°C for 10 s, annealing at 58°C for 10 s and extension at 72°C for 30 s are performed. The melting curve is measured after 2 s denaturation at 95°C followed by annealing (20 s at 50°C) and a slow increase in temperature (0.2°C/s until 98°C) to detect the temperature needed for denaturation.
Results
After the initial selection of several primer sets, the primers PKe'F (designed at the same location as the antisense primer PkR1150 from Imwong et al. [25] ) (5′-TCTTTTC TCTCCGGAGATTAGAACTC-3′) and PKg'R (5′-CAAATCCACTATATTCAATTCTACA-3′) targeting the A-type of the SSU gene were chosen for specific amplification of P. knowlesi to obtain a 312-bp amplicon. These new primers were added to the above described protocol.
The results were analysed with the threshold cycle (Ct) corresponding to the cycle at which the fluorescence signal becomes significantly different from the baseline signal and with the post-amplification melting curve analysis that is related to the sequence of the PCR products. The quantity of DNA amplified is not directly equivalent to the parasitaemia present in the original blood sample. Amplifications of each of the five Plasmodium species with their specific primers result in specific melting temperatures: 78°C for P. falciparum, 79°C for P. ovale, 80°C for P. vivax, 74°C for P. malariae and 86°C for P. knowlesi. For each primer set, non-specific amplification was excluded by the lack of amplification and melting curve with DNA of the four other species as with non-infected blood samples. The specificity of this assay was tested by using other common blood pathogens, such as Candida albicans, Toxoplasma gondii, Staphylococcus aureus, Pseudomonas aeruginosa, cytomegalovirus and hepatitis B virus. All of these control pathogens resulted in negative amplification, demonstrating the specificity of the primers (Fig. 1) .
The analytical sensitivity was determined with the concentration of the last positive amplicon obtained with a a b Fig. 1 a, b Specific detection of Plasmodium knowlesi with the primers PKe'F and PKg'R in SYBR Green real-time polymerase chain reaction (PCR). a Amplification curve of P. knowlesi. Samples containing DNA from P. falciparum, P. vivax, P. ovale and P. malariae did not result in the amplification of DNA with the primers PKe'F and PKg'R. b Melting curves analysis. The melting temperature obtained with the P. knowlesi-specific primers PKe'F and PKg'R is 86°C (±0.5°C). No curve was obtained using the same primers with the other human Plasmodium species reliable reproducibility to be 10 2 copies/μl (corresponding to a Ct=34 cycles).
Discussion
As the number of human P. knowlesi cases increases, clinicians and laboratory personnel should be alerted to this emerging-and potentially even lethal-cause of malaria, especially as it is easily misidentified as less dangerous P. malariae on microscopy [22] . Until now, the gold standard in malaria diagnosis is, indeed, based on microscopic examination of blood films, but it remains difficult to detect mixed infections, low parasitaemia, atypical forms of Plasmodium spp. potentially modified by treatment, as well as this fifth species, P. knowlesi. During the last several years, conventional methods have been improved by molecular tools. Therefore, laboratories should now be able to confirm or exclude the diagnosis of P. knowlesi malaria. Due to the uncertainty in identifying this species by microscopic analysis, and the absence of a reliable specific and sensitive rapid diagnostic test, molecular techniques are now the key for achieving this diagnosis.
In this study, we developed a real-time PCR analysis based on SYBR Green in order to identify P. knowlesi in addition to the four other human malaria species. Importantly, this technology remains low cost in comparison with the use of FRET probes. The method is suited for use in both non-endemic areas such as Europe, where only travellers with fever need to be tested, and also in endemic areas in Southeast Asia, where large-scale testing is required. The numbers of imported cases from travellers are certainly underestimated due to the difficulties in identifying exactly the species involved. Moreover, the areas of potential spread in South and Southeast Asia where the vector mosquito has spread [18] should be explored more thoroughly in order to obtain accurate information on the distribution of the disease. Novel accurate tests such as the one presented here are needed as tools for such investigations. They are also needed for diagnostics in the ordinary laboratories investigating patient samples from endemic areas or from travellers returning with fever from such areas.
